Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites

Food and Chemical Toxicology

Volumn 93, Issue , 2016, Pages 145-157

  Liu, Qianying ^a   Zhang, Jianwu ^a   Luo, Xun ^a   Ihsan, Awais ^c   Liu, Xianglian ^a   Dai, Menghong ^b   Cheng, Guyue ^b   Hao, Haihong ^b   Wang, Xu ^b   Yuan, Zonghui ^a,b  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b Hubei Collaborative Innovation Centre for Animal Nutrition and Feed Safety   (China)

^c COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Genotoxicity; Mequindox; Metabolites; Olaquindox; Quinocetone; Quinoxaline di N Oxides

Indexed keywords

CARBADOX; CIADOX; MEQUINDOX; OLAQUINDOX; QUINOCETONE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG; AMINE OXIDE;

AMES TEST; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW ERYTHROCYTE; CHEMICAL STRUCTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE MUTATION; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MICRONUCLEUS TEST; MOUSE; NONHUMAN; ANIMAL; CHEMISTRY; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; LYMPHOMA; MUTAGEN TESTING; PATHOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; CHROMOSOME ABERRATIONS; CYCLIC N-OXIDES; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; LYMPHOMA; MICE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; QUINOXALINES; SALMONELLA TYPHIMURIUM;

EID: 84969244083     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.04.029     Document Type: Article

References (97)

1. Ames B. Chemical Mutagens 1971, vol. 1:267. Plenum Press, New York.
2. Brambilla G., Martelli A. Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products. Mutat. Res. 2007, 635:17-52.
3. Brambilla G., Martelli A. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. Mutat. Res. 2009, 681:209-229.
4. Brambilla G., Mattioli F., Robbiano L., Martelli A. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity. Mutat. Res. 2010, 705:20-39.
5. Burke D.A., Wedd D.J., Burlinson B. Use of the miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry. Mutagenesis 1996, 11:201-205.
6. Carta A., Corona P., Loriga M. Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities. Curr. Med. Chem. 2005, 12:2259-2272.
7. Chen Q., Chen Y., Qi Y., Hao L., Tang S., Xiao X. Characterization of carbadox-induced mutagenesis using a shuttle vector pSP189 in mammalian cells. Mutat. Res. 2008, 638:11-16.
8. Chen Q., Tang S., Jin X., Zou J., Chen K., Zhang T., Xiao X. Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem. Toxicol. 2009, 47:328-334.
9. Cheng G., Li B., Wang C., Zhang H., Liang G., Weng Z., Hao H., Wang X., Liu Z., Dai M., Wang Y., Yuan Z. Systematic and molecular basis of the antibacterial action of quinoxaline 1,4-di-N-oxides against Escherichia coli. PLoS One 2015, 10:e0136450.
10. Chinese Toxicology Assessment Procedure and Method for Food Safety 2003, GB15193.13-2003.
11. Cihak R., Srb V. Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. I. Micronucleus test in rats. Mutat. Res. 1983, 116:129-135.
12. Cihak R., Vontorkova M. Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. III. Transplacental micronucleus test in mice. Mutat. Res. 1985, 144:81-84.
13. Clements J. The mouse lymphoma assay. Mutat. Res. 2000, 455:97-110.
14. Dai C., Tang S., Li D., Zhao K., Xiao X. Curcumin attenuates quinocetone-induced oxidative stress and genotoxicity in human hepatocyte L02 cells. Toxicol. Mech. Methods 2015, 25:340-346.
15. EC Commission regulation (EC) No. 2788/98. Off. J. Eur. Commun. 1998, L347:31.
16. EFSA European Food Safety Authority, scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA J. 2011, 9(9):1-69. http://www.efsa.europa.eu/efsajournal.
17. El-Khatib M., Geara F., Haddadin M.J., Gali-Muhtasib H. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21. Radiat. Oncol. 2010, 5.
18. European Guidelines of the Scientific Committee on Food for the Presentation of an Application for Safety Assessment of a Substance to be Used in Food Contact Materials Prior to its Authorization 2001.
19. FAO/WHO Joint Expert Committee on Food Additives. Evaluation of certain veterinary drug residues in good. Techn. Ser. 1990, 799:45.
20. FDA Toxicological Principles for the Safety Assessment of Food Ingredients, IV.C.1, Short-term Tests for Genetic Toxicity 2000.
21. FDA Toxicological Principles for the Safety Assessment of Food Ingredients. IV.C.1.a. Bacterial Reverse Mutation Test 2000.
22. FDA Toxicological Principles for the Safety Assessment of Food Ingredients. IV C 1 d. Mammalian Erythrocyte Micronucleus Test 2000.
23. FDA Toxicological Principles for the Safety Assessment of Food Ingredients. IV.C.1.b. In Vitro Mammalian Chromosomal Aberration Test 2000.
24. FDA Toxicological Principles for the Safety Assessment of Food Ingredients. IV.C.1.c. In Vitro Mouse Lymphoma TK +/- Gene Mutation Assay 2000.
25. Ganley B., Chowdhury G., Bhansali J., Daniels J.S., Gates K.S. Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide. Bioorg. Med. Chem. 2001, 9:2395-2401.
26. Hao L., Chen Q., Xiao X. Molecular mechanism of mutagenesis induced by olaquindox using a shuttle vector pSP189/mammalian cell system. Mutat. Res. 2006, 599:21-25.
27. He Q., Fang G., Wang Y., Wei Z., Wang D., Zhou S., Fan S., Yuan Z. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin. Photodermatol. Photoimmunol. Photomed. 2006, 22:100-104.
28. Healy C.E., Kier L.D., Broeckaert F., Martens M.A. A review of the genotoxicity of triallate. Int. J. Toxicol. 2003, 22:233-251.
29. Hellauer K., Lesage G., Sdicu A.M., Turcotte B. Large-scale analysis of genes that alter sensitivity to the anticancer drug tirapazamine in Saccharomyces cerevisiae. Mol. Pharmacol. 2005, 68:1365-1375.
30. Honma M., Hayashi M., Shimada H., Tanaka N., Wakuri S., Awogi T., Yamamoto K.I., Kodani N., Nishi Y., Nakadate M., Sofuni T. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 1999, 14:5-22.
31. Honma M., Zhang L.Z., Sakamoto H., Ozaki M., Takeshita K., Momose M., Hayashi M., Sofuni T. The need for long-term treatment in the mouse lymphoma assay. Mutagenesis 1999, 14:23-29.
32. Hu G.Z., Zhang S.M., Liu X.L., Zhan G.C. In vivo mutagenic and teratogenic studies of domestic sarafloxacin. J. Huazhong Argic. Univ. 2001, 20(3):268-270.
33. IARC Some pharmaceutical drugs. IARC Monogr. Eval. Carcinog. Risk Hum. 1980, 24:59-76.
34. ICH Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use S 2008.
35. ICH Guidance for Industry Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use 2012.
36. Ihsan A., Wang X., Huang X.J., Liu Y., Liu Q., Zhou W., Yuan Z.H. Acute and subchronic toxicological evaluation of Mequindox in Wistar rats. Regul. Toxicol. Pharmacol. 2010, 57:307-314.
37. Ihsan A., Wang X., Liu Z., Wang Y., Huang X., Liu Y., Yu H., Zhang H., Li T., Yang C., Yuan Z. Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats. Toxicol. Appl. Pharmacol. 2011, 252:281-288.
38. Ihsan A., Wang X., Tu H.G., Zhang W., Dai M.H., Peng D.P., Wang Y.L., Huang L.L., Chen D.M., Mannan S., Tao Y.F., Liu Z.L., Yuan Z.H. Genotoxicity evaluation of Mequindox in different short-term tests. Food Chem. Toxicol. 2013, 51:330-336.
39. Ihsan A., Wang X., Zhang W., Tu H., Wang Y., Huang L., Iqbal Z., Cheng G., Pan Y., Liu Z., Tan Z., Zhang Y., Yuan Z. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem. Toxicol. 2013, 59:207-214.
40. Ishidate M., Harnois M.C., Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res. 1988, 195:151-213.
41. JECFA 36th Meeting of the Joint FAO/WHO Expert Committee on Food/Additives WHO Food Additives Series 1991, vol. 27:141.
42. JECFA WHO FOOD Additives Series: 51 2003, Carbadox (addendum). http://www.inchem.org/documents/jecfa/jecmono/v51je05.htm#2.2.
43. Jin X., Chen Q., Tang S.S., Zou J.J., Chen K.P., Zhang T., Xiao X.L. Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis. Toxicol. In Vitro 2009, 23:1209-1214.
44. Junnotula V., Sarkar U., Sinha S., Gates K.S. Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide. J. Am. Chem. Soc. 2009, 131:1015-1024.
45. Khaled Ghattass S.E.-S., Zibara Kazem, Rayes Saide, Haddadin Makhluf J., El-Sabban Marwan, Gali-Muhtasib A.H. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway. Mol. Cancer 2014, 13:12.
46. Kirkland D., Aardema M., Muller L., Makoto H. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat. Res. 2006, 608:29-42.
47. Kirkland D., Zeiger E., Madia F., Gooderham N., Kasper P., Lynch A., Morita T., Ouedraogo G., Parra Morte J.M., Pfuhler S., Rogiers V., Schulz M., Thybaud V., van Benthem J., Vanparys P., Worth A., Corvi R. Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM workshop. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 775-776:55-68.
48. Kirkland D.J., Clements J. Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA). Mutat. Res. 1998, 415:159-163.
49. Liu J., Ouyang M., Jiang J., Mu P., Wu J., Yang Q., Zhang C., Xu W., Wang L., Huen M.S., Deng Y. Mequindox induced cellular DNA damage via generation of reactive oxygen species. Mutat. Res. 2012, 741:70-75.
50. Liu Z., Huang L., Dai M., Chen D., Tao Y., Wang Y., Yuan Z. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2026-2034.
51. Liu Z., Huang L., Dai M., Chen D., Wang Y., Tao Y., Yuan Z. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22:1009-1016.
52. Liu Z.Y., Huang L.L., Chen D.M., Dai M.H., Tao Y.F., Wang Y.L., Yuan Z.H. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro. Anal. Bioanal. Chem. 2010, 396:1259-1271.
53. Liu Z.Y., Huang L.L., Chen D.M., Dai M.H., Tao Y.F., Yuan Z.H. The metabolism and N-oxide reduction of olaquindox in liver preparations of rats, pigs and chicken. Toxicol. Lett. 2010, 195:51-59.
54. Liu Z.Y., Huang L.L., Chen D.M., Yuan Z.H. Metabolism of mequindox in liver microsomes of rats, chicken and pigs. Rapid Commun. Mass Spectrom. 2010, 24:909-918.
55. Liu Z.Y., Huang L.L., Dai M.H., Chen D.M., Tao Y.F., Wang Y.L., Yuan Z.H. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2026-2034.
56. Liu Z.Y., Huang L.L., Zhou X.N., Chen D.M., Tao Y.F., Zhang H.H., Yuan Z.H. The metabolism of olaquindox in rats, chickens and pigs. Toxicol. Lett. 2011, 200:24-33.
57. Liu Z.Y., Sun Z.L. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview. Med. Chem. 2013, 9:1017-1027.
58. Liu Z.Y., Tao Y.F., Chen D.M., Wang X., Yuan Z.H. Identification of carbadox metabolites formed by liver microsomes from rats, pigs and chickens using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25:341-348.
59. Maisanaba S., Prieto A.I., Puerto M., Gutierrez-Praena D., Demir E., Marcos R., Camean A.M. In vitro genotoxicity testing of carvacrol and thymol using the micronucleus and mouse lymphoma assays. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2015, 784-785:37-44.
60. Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455:29-60.
61. Nakab L., Bardot I., Bardot S., Simar S., Marzin D., Nesslany F. In vitro and in vivo genotoxicity assessment of HI-6 dimethanesulfonate/oxime. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 762:30-38.
62. Nohynek G.J., Kirkland D., Marzin D., Toutain H., Leclerc-Ribaud C., Jinnai H. An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one]. Food Chem. Toxicol. 2004, 42:93-105.
63. NRC The development of science based guidelines for laboratory animal care. Proceedings of the November 2003 International Workshop 2004, National Academy Press, Washington, DC.
64. OECD OECD Guidelines for the Testing of Chemicals. Test Guideline 471. Bacterial Reverse Mutation Test 1997.
65. OECD OECD Guidelines for the Testing of Chemicals. Test Guideline 474. Mammalian Erythrocyte Micronucleus Test 2014.
66. OECD OECD Guidelines for the Testing of Chemicals. Test Guideline 473. In Vitro Mammalian Chromosomal Aberration Test 2014.
67. OECD OECD Guidelines for the Testing of Chemicals. Test No. 490: In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene 2015.
68. Omori T., Honma M., Hayashi M., Honda Y., Yoshimura I. A new statistical method for evaluation of L5178Ytk(+/-) mammalian cell mutation data using microwell method. Mutat. Res. 2002, 517:199-208.
69. Peters K.B., Brown J.M. Tirapazamine: a hypoxia-activated topoisomerase II poison. Cancer Res. 2002, 62:5248-5253.
70. Poole J.S., Hadad C.M., Platz M.S., Fredin Z.P., Pickard L., Guerrero E.L., Kessler M., Chowdhury G., Kotandeniya D., Gates K.S. Photochemical electron transfer reactions of tirapazamine. Photochem. Photobiol. 2002, 75:339-345.
71. Rogers A.M., Back K.C. Comparative mutagenicity of hydrazine and 3 methylated derivatives in L5178Y mouse lymphoma cells. Mutat. Res. 1981, 89:321-328.
72. Suter W., Hartmann A., Poetter F., Sagelsdorff P., Hoffmann P., Martus H.J. Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound. Mutat. Res. 2002, 518:181-194.
73. Swierenga S.H., Heddle J.A., Sigal E.A., Gilman J.P., Brillinger R.L., Douglas G.R., Nestmann E.R. Recommended protocols based on a survey of current practice in genotoxicity testing laboratories, IV. Chromosome aberration and sister-chromatid exchange in Chinese hamster ovary, V79 Chinese hamster lung and human lymphocyte cultures. Mutat. Res. 1991, 246:301-322.
74. Vicente E., Perez-Silanes S., Lima L.M., Ancizu S., Burguete A., Solano B., Villar R., Aldana I., Monge A. Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides. Bioorg. Med. Chem. 2009, 17:385-389.
75. VICH Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies 2000.
76. Von wright A., Tikkanen L. The comparative mutagenicities of hydrazine and its mono- and di- methyl derivatives in bacterial test systems. Mutat. Res. 1980, 78:17-23.
77. Wang X., Fang G.J., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Liu Z.L., Yuan Z.H. Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats. Food Chem. Toxicol. 2011, 49:1068-1079.
78. Wang X., He Q.H., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Su S.J., Liu Z.L., Yuan Z.H. A chronic toxicity study of cyadox in Wistar rats. Regul. Toxicol. Pharmacol. 2011, 59:324-333.
79. Wang X., Huang X.J., Ihsan A., Liu Z.Y., Huang L.L., Zhang H.H., Zhang H.F., Zhou W., Liu Q., Xue X.J., Yuan Z.H. Metabolites and JAK/STAT pathway were involved in the liver and spleen damage in male Wistar rats fed with mequindox. Toxicology 2011, 280:126-134.
80. Wang X., Yang P., Li J., Ihsan A., Liu Q., Cheng G., Tao Y., Liu Z., Yuan Z. Genotoxic risk of quinocetone and its possible mechanism in in vitro studies. Toxicol. Res. 2016, 5:446-460.
81. Wang X., Zhang H., Huang L., Pan Y., Li J., Chen D., Cheng G., Hao H., Tao Y., Liu Z., Yuan Z. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides. Chem. Res. Toxicol. 2015, 28:470-481.
82. Wang X., Zhou W., Ihsan A., Chen D., Cheng G., Hao H., Liu Z., Wang Y., Yuan Z. Assessment of thirteen-week subchronic oral toxicity of cyadox in Beagle dogs. Regul. Toxicol. Pharmacol. 2015, 73:652-659.
83. World Health Organization (WHO) Toxicological Evaluation of Certain Veterinary Drug Residues in Food 1991, Carbadox. WHO Food Additives Series, No. 27, No. 700 on INCHEM.
84. World Health Organization (WHO) Toxicological Evaluation of Certain Veterinary Drug Residues in Food 1991, Olaquindox. WHO Food Additives Series, No. 27, no. 701 on INCHEM.
85. Woodward K.N. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union. Regul. Toxicol. Pharmacol. 2008, 50:114-128.
86. Wu H., Li L., Shen J., Wang Y., Liu K., Zhang S. In vitro metabolism of cyadox in rat, chicken and swine using ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2012, 67-68:175-185.
87. Wu X.X., Yang Q.Y., Guan S.H., Peng C.N., Li R.L. Study on mutagenicity of ciprofloxacin. Teratog. Carcin. Mut. 1991, 3:125-126.
88. Wu Y., Yu H., Wang Y., Huang L., Tao Y., Chen D., Peng D., Liu Z., Yuan Z. Development of a high-performance liquid chromatography method for the simultaneous quantification of quinoxaline-2-carboxylic acid and methyl-3-quinoxaline-2-carboxylic acid in animal tissues. J. Chromatogr. A 2007, 1146:1-7.
89. Yang W., Fu J., Xiao X., Yan H., Bao W., Wang D., Hao L., Nussler A.K., Yao P., Liu L. Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders. J. Sci. Food Agric. 2013, 93:1317-1325.
90. Zeiger E. Mutagens that are not carcinogens: faulty theory or faulty tests?. Mutat. Res. 2001, 492:29-38.
91. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K., Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen 1987, 9(Suppl. 9):1-109.
92. Zeiger E., Hoffmann G.R. An illusion of hormesis in the Ames test: statistical significance is not equivalent to biological significance. Mutat. Res. 2012, 746:89-93.
93. Zhang J., Cao J., Weng Q.J., Wu R., Yan Y., Jing H., Zhu H., He Q.J., Yang B. Suppression of hypoxia-inducible factor 1 alpha (HIF-1 alpha) by tirapazamine is dependent on eIF2 alpha phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One 2010, 5(11):e13910.
94. Zhang K., Ban M., Zhao Z., Zheng H., Wang X., Wang M., Fei C., Xue F. Cytotoxicity and genotoxicity of 1,4-bisdesoxyquinocetone, 3-methylquinoxaline-2-carboxylic acid (MQCA) in human hepatocytes. Res. Vet. Sci. 2012, 93:1393-1401.
95. Zhang K., Wang X., Wang C., Zheng H., Li T., Xiao S., Wang M., Fei C., Zhang L., Xue F. Investigation of quinocetone-induced mitochondrial damage and apoptosis in HepG2 cells and compared with its metabolites. Environ. Toxicol. Pharmacol. 2015, 39:555-567.
96. Zhang K., Zheng W., Zheng H., Wang C., Wang M., Li T., Wang X., Zhang L., Xiao S., Fei C., Xue F. Identification of oxidative stress and responsive genes of HepG2 cells exposed to quinocetone, and compared with its metabolites. Cell Biol. Toxicol. 2014, 30:313-329.
97. Zhou M.S., Lin F.T. Study on the mutagenicity of fleroxacin. Chin. J. Antibiot. 1996, 21(1):51-53.